Try our Advanced Search for more refined results

November 09, 2006

United States of America ex rel. Bernard Lisitza et al v. Par Pharmaceutical Companies, Inc. et al

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. August 18, 2017

    Par Pharmaceutical Beats FCA Prescription-Switch Claims

    Par Pharmaceutical Cos. Inc. beat False Claims Act allegations brought by a retired pharmacist, the U.S. and two states, when an Illinois federal judge ruled Thursday that the pharmacist was not the original source for the prescription-switching allegations and that the Medicaid claims were not actually shown to be false.

1 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login